Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of Lapatinib Administered With Capecitabine in Japanese Patients With ErbB2 Overexpressing Advanced or Metastatic Breast Cancer

NCT00477464 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00477464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00477464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of Lapatinib Administered With Capecitabine in Japanese Patients With ErbB2 Overexpressing Advanced or Metastatic Breast Cancer
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2007
Completion date
December 31, 2010
Enrollment
51 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer, neoplasms, breast